Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures


Creative Commons License

Kurt M., Onal I. K., Akdogan M., Kekilli M., Arhan M., Sayilir A., ...Daha Fazla

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.24, sa.6, ss.380-384, 2010 (SCI-Expanded) identifier identifier

Özet

OBJECTIVE: To assess the hemostatic efficacy of the Ankaferd Blood Stopper (ABS, Ankaferd Health Products Ltd, Turkey) hemostatic agent for controlling gastrointestinal bleeding associated with various benign lesions refractory to conventional antihemorrhagic measures.